Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah J E Marriott

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Therapeutic Drug Monitoring|December 9, 2021
Optimal Practice for Vancomycin Therapeutic Drug Monitoring: Position Statement From the Anti-infectives Committee of the International Association of Therapeutic Drug Monitoring and Clinical ToxicologyStephanie E Reuter, Sophie L Stocker, Jan-Willem C Alffenaar, et al.
Mycoses|November 13, 2020
Risk factors for candidaemia: A prospective multi-centre case-control studyCaitlin Livia Keighley, Alun Pope, Deborah J E Marriott, et al.
Clinical Pharmacology and Therapeutics|November 15, 2020
Evaluation of a Pilot Vancomycin Precision Dosing Advisory Service on Target Exposure Attainment Using an Interrupted Time Series AnalysisSophie L Stocker, Jane E Carland, Stephanie E Reuter, et al.
Infection|October 14, 2025
A fluconazole population pharmacokinetics study to improve target attainment in critically ill patientsMy-Luong Vuong, Omar Elkayal, Ruth Van Daele, et al.
Clinical Pharmacokinetics|July 30, 2020
Pharmacokinetics/Pharmacodynamics of Antiviral Agents Used to Treat SARS-CoV-2 and Their Potential Interaction with Drugs and Other Supportive Measures: A Comprehensive Review by the PK/PD of Anti-Infectives Study Group of the European Society of Antimicrobial AgentsMarkus Zeitlinger, Birgit C P Koch, Roger Bruggemann, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Therapeutic Drug Monitoring|December 9, 2021
Optimal Practice for Vancomycin Therapeutic Drug Monitoring: Position Statement From the Anti-infectives Committee of the International Association of Therapeutic Drug Monitoring and Clinical ToxicologyStephanie E Reuter, Sophie L Stocker, Jan-Willem C Alffenaar, et al.
Mycoses|November 13, 2020
Risk factors for candidaemia: A prospective multi-centre case-control studyCaitlin Livia Keighley, Alun Pope, Deborah J E Marriott, et al.
Clinical Pharmacology and Therapeutics|November 15, 2020
Evaluation of a Pilot Vancomycin Precision Dosing Advisory Service on Target Exposure Attainment Using an Interrupted Time Series AnalysisSophie L Stocker, Jane E Carland, Stephanie E Reuter, et al.
Infection|October 14, 2025
A fluconazole population pharmacokinetics study to improve target attainment in critically ill patientsMy-Luong Vuong, Omar Elkayal, Ruth Van Daele, et al.
Clinical Pharmacokinetics|July 30, 2020
Pharmacokinetics/Pharmacodynamics of Antiviral Agents Used to Treat SARS-CoV-2 and Their Potential Interaction with Drugs and Other Supportive Measures: A Comprehensive Review by the PK/PD of Anti-Infectives Study Group of the European Society of Antimicrobial AgentsMarkus Zeitlinger, Birgit C P Koch, Roger Bruggemann, et al.
Pageof 3